|
|
SPOT ON
|
|
Clinical trials with biologicals in healthy subjects: study protocols must not be confidential
|
|
|
NEW INDICATION
|
|
TNF-alpha-antibody Infliximab (REMICADE) for psoriasis
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Clopidogrel (ISCOVER; PLAVIX) plus aspirin in long-term secondary prevention?
Fondaparinux (ARIXTRA) in acute coronary syndrome or myocardial infarction?
|
|
|
IN BRIEF
|
|
Myocardial infarction: enoxaparin (CLEXANE) versus unfractionated heparin (e.g. LIQUEMIN)
Reference pricing for proton pump inhibitor PANTOZOL: fairy-tales from Altana
Advertisement for DELIX: dupery
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Is pelargonium-extract (UMCKALOABO) hepatotoxic?
|
|
|
SIDE EFFECTS
|
|
Topical pimecrolimus (e.g. ELIDEL) and tacrolimus (PROTOPIC): suspicion of carcinogenicity unchanged
|
|